Clinicopathological, endoscopic, and molecular characteristics of the “skirt” – a new entity of lesions at the margin of laterally spreading tumors

Background and study aim: A slightly elevated flat lesion with wide pits has occasionally been observed at the margin of laterally spreading tumors (LSTs) and is known as a “skirt.” The aim of this study was to evaluate the clinicopathological, endoscopic, and genetic characteristics of a skirt.

Patients and methods: Consecutive LSTs were examined to evaluate the pathological, endoscopic, and genetic characteristics. Pathological characteristics, including the dimension of the cryptic opening (DCO), width of the individual gland (WIG), DCO to WIG ratio, and microvessel diameter were elucidated and compared with those of hyperplastic polyps, low grade dysplasia (LGD), and normal mucosa. The endoscopic findings of pit and microvascular patterns were assessed. Gene mutation analyses were performed for the KRAS, BRAF, NRAS, and PIK3CA genes.

Results: A skirt was identified in 35 of 1023 LSTs, and 80 % of lesions with a skirt had a component of either intramucosal or submucosal adenocarcinoma. The DCO, WIG, and DCO to WIG ratio of the skirt were significantly larger than those of other lesions. The microvessel diameters in skirts were significantly smaller than those in LGDs. Regarding the endoscopic findings, 30 skirts showed pits with a coral reef-like appearance, and all skirt regions were found to have a type I capillary pattern. KRAS mutation at codon 146 was found in the nodular part in one of five LSTs with a skirt.

Conclusion: The skirt is a newly identified lesion distinct from hyperplastic polyps and LGDs, suggesting the presence of a novel pathway for rectal carcinogenesis from LSTs with a skirt.

• References

• 1 Miyamoto H, Ikematsu H, Fujii S et al. Clinicopathological differences of laterally spreading tumors arising in the colon and rectum. Int J Colorectal Dis 2014; 29: 1069-1075
• 2 Tamura S, Nakajo K, Yokoyama Y et al. Evaluation of endoscopic mucosal resection for laterally spreading rectal tumors. Endoscopy 2004; 36: 306-312
• 3 Whitehouse PA, Armitage JN, Tilney HS et al. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer. Colorectal Dis 2008; 10: 187-193
• 4 Sutton CD, Marshall LJ, White SA et al. Ten-year experience of endoscopic transanal resection. Ann Surg 2002; 235: 355-362
• 5 Palma P, Freudenberg S, Samel S et al. Transanal endoscopic microsurgery: indications and results after 100 cases. Colorectal Dis 2004; 6: 350-355
• 6 Dafnis G, Pahlman L, Raab Y et al. Transanal endoscopic microsurgery: clinical and functional results. Colorectal Dis 2004; 6: 336-342
• 7 Mihai R, Borley N. Transanal endoscopic microsurgery – impact on the practice of a colorectal surgeon in a district general hospital. Ann R Coll Surg Engl 2005; 87: 432-436
• 8 Kiriyama S, Saito Y, Matsuda T et al. Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 2011; 26: 1028-1033
• 9 Miyamoto H, Oono Y, Fu KL et al. Morphological change of a laterally spreading rectal tumor over a short period. BMC Gastroenterol 2013; 13: 129
• 10 Bando H, Yoshino T, Shinozaki E et al. Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit. BMC Cancer 2013; 13: 405
• 11 World Health Organization classification of tumours of the digestive system. Lyon: IARC Press; 2010: 131-182
• 12 Fukushima Y, Yanaka S, Murakami K et al. [High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer]. Gan To Kagaku Ryoho 2011; 38: 1825-1835
• 13 Sano Y, Ikematsu H, Fu KI et al. Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps. Gastrointest Endosc 2009; 69: 278-283
• 14 Konerding MA, Fait E, Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 2001; 84: 1354-1362
• 15 Fait E, Malkusch W, Junginger T et al. Microvascularization of human colorectal adenocarcinomas: 3D SEM studies on corrosion casts. J Vasc Res 1998; 35: 228
• 16 Skinner SA, Frydman GM, O’Brien PE. Microvascular structure of benign and malignant tumors of the colon in humans. Dig Dis Sci 1995; 40: 373-384
• 17 Fujiya M, Saitoh Y, Nomura M et al. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 2002; 56: 535-542
• 18 Kunihiro M, Tanaka S, Sumii M et al. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation. Inflamm Bowel Dis 2004; 10: 737-744
• 19 Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004; 126: 1634-1648
• 20 Hiraoka S, Kato J, Tatsukawa M et al. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology 2006; 131: 379-389
• 21 Mukawa K, Fujii S, Takeda J et al. Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors. J Gastroenterol Hepatol 2005; 20: 1584-1590
• 22 Loupakis F, Ruzzo A, Cremolini C et al. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer 2009; 101: 715-721
• 23 De Roock W, Claes B, Bernasconi D et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 2010; 11: 753-762
• 24 Nakae K, Mitomi H, Saito T et al. MUC5AC/beta-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors. World J Gastroenterol 2012; 18: 5551-5559
• 25 Sugimoto T, Ohta M, Ikenoue T et al. Macroscopic morphologic subtypes of laterally spreading colorectal tumors showing distinct molecular alterations. Int J Cancer 2010; 127: 1562-1569
• 26 Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011; 42: 1-10
• 27 Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-2100
• 28 Bettington M, Walker N, Clouston A et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-386
• 29 Jass JR, Baker K, Zlobec I et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer. Histopathology 2006; 49: 121-131
• 30 O’Brien MJ, Yang S, Mack C et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006; 30: 1491-1501
• 31 Spring KJ, Zhao ZZ, Karamatic R et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131: 1400-1407
• 32 Carr NJ, Mahajan H, Tan KL et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009; 62: 516-518